Which measures the known degree of protein produced by ovarian cancer cells in the blood.

CT scans and other imaging techniques are often used in sufferers with recurrent cancer to assess if the patient is giving an answer to treatment. RECIST, the standard criteria for analyzing CT ultrasonography and scans, assesses treatment response by measuring the development or shrinkage of the tumor. However, unlike additional solid tumors, ovarian cancers spreads through the tummy diffusely, making tumor tissue much more tough to detect through CT scans. As a total result, response cannot be measured by RECIST criteria always.‘Our results suggest that raising the quality of collaboration and conversation among nurses and physicians has the potential to boost patient safety,’ said research author Christine Boev, RN, PhD, CCRN. ‘Efforts to prevent healthcare-associated infections must consist of interventions to boost nurse-physician collaboration.’ Related StoriesOJ Bio at Medica 2015 – Point of Care diagnostics' part in reducing antibiotics prescribingReducing medical center readmissions through Transitional Care: an interview with Rani KhetarpalCancer medical diagnosis improvements in England: an interview with Lucy Elliss-BrookesBoev can be an assistant professor, Wegmans School of Nursing, St.